These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 592333)

  • 21. Marked inhibition of histamine formation in transplantable histamine-producing gastric carcinoid of Mastomys natalensis by (S)-alpha-fluoromethylhistidine and its potent antiulcer effect on tumor-bearing hosts.
    Hosoda S; Saito T; Kumazawa H; Watanabe T; Wada H
    Biochem Pharmacol; 1985 Dec; 34(24):4327-9. PubMed ID: 4074392
    [No Abstract]   [Full Text] [Related]  

  • 22. Identification and measurement of acid (specific) histidine decarboxylase activity in rabbit gastric mucosa: ending an old controversy?
    Neugebauer E; Lorenz W
    Biol Chem Hoppe Seyler; 1985 Apr; 366(4):411-20. PubMed ID: 4026995
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vitro inhibition of rat hypothalamus histidine decarboxylase by a specific inhibitor--4-imidazolyl-3-amino-2-butanone (McN-A-1293).
    Bielkiewicz B; Maslinski C
    Biochem Pharmacol; 1978; 27(24):2977-8. PubMed ID: 736993
    [No Abstract]   [Full Text] [Related]  

  • 24. Reaction of Lactobacillus histidine decarboxylase with L-histidine methyl ester.
    Alston TA; Abeles RH
    Biochemistry; 1987 Jun; 26(13):4082-5. PubMed ID: 3651438
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vivo and in vitro inhibition of human histidine decarboxylase by (S)-alpha-fluoromethylhistidine.
    Tung AS; Blake JT; Roman IJ; Vlasses PH; Ferguson RK; Zweerink HJ
    Biochem Pharmacol; 1985 Oct; 34(19):3509-15. PubMed ID: 4052095
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Application of 13C-NMR spectroscopy to in vitro analysis of enzyme kinetics.
    Johnson HL; Thomas DW; Ellis M; Cary L; DeGraw JI
    J Pharm Sci; 1977 Nov; 66(11):1660-2. PubMed ID: 199715
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bioanalysis and disposition of alpha-fluoromethylhistidine, a new histidine decarboxylase inhibitor.
    August TF; Musson DG; Hwang SS; Duggan DE; Hooke KF; Roman IJ; Ferguson RJ; Bayne WF
    J Pharm Sci; 1985 Aug; 74(8):871-5. PubMed ID: 4032273
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibitors of histidine decarboxylase decrease basal gastric acid secretion in the rat.
    Westerberg VS; Geiger JD
    Pharmacol Biochem Behav; 1987 Nov; 28(3):419-22. PubMed ID: 3685079
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Histidine decarboxylase of Lactobacillus 30a: inactivation and active-site labeling by L-histidine methyl ester.
    Lane RS; Manning JM; Snell EE
    Biochemistry; 1976 Sep; 15(19):4180-5. PubMed ID: 963031
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Peptide inhibition of mammalian histidine decarboxylase.
    Hammar L; Ragnarsson U
    Agents Actions; 1979 Oct; 9(4):314-8. PubMed ID: 117688
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of alpha-fluoromethylhistidine (FMH), an irreversible inhibitor of histidine decarboxylase, on development of brain histamine and catecholamine systems in the neonatal rat.
    Slotkin TA; Slepetis RJ; Weigel SJ; Whitmore WL
    Life Sci; 1983 Jun; 32(25):2897-903. PubMed ID: 6855476
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibition of gastric acid secretion by 4-imidazolyl-3-amino-2-butanone (McN-A-1293), a specific inhibitor of histidine decarboxylase.
    Taylor RJ
    Biochem Pharmacol; 1978; 27(22):2653-4. PubMed ID: 728219
    [No Abstract]   [Full Text] [Related]  

  • 33. Inactivation of rat gastric mucosal histidine decarboxylase by phosphatase.
    Savany A; Cronenberger L
    Biochem Int; 1989 Aug; 19(2):429-38. PubMed ID: 2554911
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Involvement of histamine in growth of mouse and rat tumors: antitumoral properties of monofluoromethylhistidine, an enzyme-activated irreversible inhibitor of histidine decarboxylase.
    Bartholeyns J; Bouclier M
    Cancer Res; 1984 Feb; 44(2):639-45. PubMed ID: 6692368
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of histidine, decarboxylation in vivo by 2-hydroxy-5-carbomethoxybenzyloxyamine, a new, potent inhibitor of histidine decarboxylase.
    Huszti Z; Sourkes TL
    J Pharmacol Exp Ther; 1975 Feb; 192(2):432-40. PubMed ID: 235021
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Selective inhibitors of biosynthesis of aminergic neurotransmitters.
    Kollonitsch J; Perkins LM; Patchett AA; Doldouras GA; Marburg S; Duggan DE; Maycock AL; Aster SD
    Nature; 1978 Aug; 274(5674):906-8. PubMed ID: 683331
    [No Abstract]   [Full Text] [Related]  

  • 37. The characterization of histidine decarboxylase and its distribution in nerves, ganglia and in single neuronal cell bodies from the CNS of Aplysia californica.
    Weinreich D; Yu Y-T
    J Neurochem; 1977 Feb; 28(2):361-9. PubMed ID: 839218
    [No Abstract]   [Full Text] [Related]  

  • 38. Properties of rat brain histidine decarboxylase.
    Palacios JM; Mengod G; Picatoste F; Grau M; Blanco I
    J Neurochem; 1976 Dec; 27(6):1455-60. PubMed ID: 12251
    [No Abstract]   [Full Text] [Related]  

  • 39. Developmental effects of alpha-fluoromethylhistidine, an irreversible inhibitor of histidine decarboxylase, on growth and on levels and turnover of catecholamines.
    Slotkin TA; Bartolome J; Whitmore WL
    Life Sci; 1983 Nov; 33(21):2137-45. PubMed ID: 6645794
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of histidine decarboxylase and tumour promoter-induced arachidonic acid release by lecanoric acid analogues.
    Umezawa K; Muramatsu S; Ishizuka M; Sawa T; Takeuchi T; Matsushima T
    Biochem Biophys Res Commun; 1983 Feb; 110(3):733-9. PubMed ID: 6404261
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.